Pulse Biosciences, Inc. Non Peo Neo Avg Total Comp Amt
Pulse Biosciences, Inc. (PLSE) reported Non Peo Neo Avg Total Comp Amt of $1.86 million for the 12-month period ending 2025-12-31, per its DEF 14A filed 2026-05-11.
Financial Statements › Notes
ecd:NonPeoNeoAvgTotalCompAmt · last filed 2026-05-11
| Period end | Non Peo Neo Avg Total Comp Amt 12 month |
|---|---|
| 2025-12-31 | $1.86M DEF 14A · filed 2026-05-11 |
| 2024-12-31 | $616.41K DEF 14A · filed 2026-05-11 |
| 2023-12-31 | $3.52M DEF 14A · filed 2026-05-11 |
| 2022-12-31 | $424.29K DEF 14A · filed 2026-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |